Sign in
4

Changes in Ownership

BIODESIX INC Filed Acc 0001140361-22-018735

Chief Accounting Officer sold 1,947 shares at $1.83 ($3,563)

  • Chief Accounting Officer acquired 5,484 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Siurek Ryan H · Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-09 Exercise or conversion : show line 1 in the form +5,484 9,350 D
2022-05-10 Sale : show line 2 in the form −1,947 $1.83 $3,563 7,403 D
Open-market sales · 1,947 sh · avg $1.83 · $3,563

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2022-05-09 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,927 1,927 28,899 D
2022-05-09 Exercise or conversion : show line 4 in the form Restricted Stock Units −3,557 3,557 17,784 D
Loading xslF345X03/form4.xml…